Dialysis Clinical Outcomes Revisited (DCOR) Trial

NCT00324571 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Sevelamer hydrochloride
DRUG: Calcium-based phosphate binder

Sponsor

Genzyme, a Sanofi Company